This inventor holds 1 USPTO granted patent. Top assignee: The Queen's University of Belfast. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations of John Nelson in Peptide Research
Introduction
John Nelson is a notable inventor based in Belfast, Ireland. He has made significant contributions to the field of peptide research, particularly in the area of epidermal growth factors. His work focuses on developing peptide fragments that have potential applications in medical science.
Latest Patents
John Nelson holds a patent for "Peptide fragments of murine epidermal growth factor as laminin receptor targets." This patent describes a peptide factor and its analogs, which are modified to protect them from proteolytic degradation. The peptide binds to laminin receptors, showcasing its potential for therapeutic applications.
Career Highlights
John Nelson is affiliated with The Queen's University of Belfast, where he conducts his research. His work has garnered attention for its innovative approach to peptide modification and its implications in medical treatments.
Collaborations
John collaborates with esteemed colleagues such as Patrick Harriott and Brian Walker. Their combined expertise enhances the research output and fosters a collaborative environment for innovation.
Conclusion
John Nelson's contributions to peptide research exemplify the intersection of innovation and medical science. His patented work on epidermal growth factors highlights the potential for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile